Registry Study of Assistive Devices, Medicines and Healthcare Measures in ALS, SMA and Other Neurological Diseases.

NCT ID: NCT05852418

Last Updated: 2025-01-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

25000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-10-30

Study Completion Date

2029-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This registry study aims to collect data on the provision of assistive devices, medicines, and other healthcare measures, such as ventilation therapy and nutrition support, in patients with Amyotrophic lateral sclerosis (ALS), Spinal muscular atrophy (SMA) and other neurological disorders. The data collected should describe the clinical practice, meaning real-world evidence and patient-reported outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This registry study aims to collect data on the provision of assistive devices, medicines, and other healthcare measures, such as ventilation therapy and nutrition support, in patients with ALS, SMA and other neurological disorders. The data collected should describe the clinical practice, meaning real-world evidence and patient-reported outcomes. The collected data include clinical characteristics, medical history, assessment scales, such as ALS functional rating scale-revised (ALSFRS-R), prognosis indicators, such as ALS progression rate, biomarker data, such as serum Neurofilament light chain (sNfL), genetic data, such as the mutation status of SOD1, FUS, c9orf72, TARDBP in ALS, SMN1 in SMA patients, innovative drugs such as Tofersen, Nusinersen, Risdiplam, as well as symptomatic drugs, patient-reported outcome data being captured using questionnaires and established clinical scales on medication expectation and treatment satisfaction.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Amyotrophic Lateral Sclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Exclusion Criteria

\-
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Charite University, Berlin, Germany

OTHER

Sponsor Role collaborator

Ambulanzpartner Soziotechnologie APST GmbH

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thomas Meyer, Prof. Dr.

Role: STUDY_DIRECTOR

Ambulanzpartner Soziotechnologie APST GmbH

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Christoph Münch

Berlin, , Germany

Site Status RECRUITING

Neurologische Klinik und Poliklinik, Universitätsklinikum Bergmannsheil

Bochum, , Germany

Site Status RECRUITING

Klinik für Neurodegenrative Erkrankungen und Gerontopsychiatrie, ALS-Ambulanz und Huntington Ambulanz, Universitätsklinikum

Bonn, , Germany

Site Status RECRUITING

Klinik und Poliklinik für Neurologie, Medizinische Fakultät Carl Gustav Carus, Technischen Universität Dresden

Dresden, , Germany

Site Status RECRUITING

Neurologische Klinik, ALS-Ambulanz, Alfried Krupp Krankenhaus Rüttenscheid, Essen

Essen, , Germany

Site Status RECRUITING

Klinik für Neurologie, Universitätsmedizin, Georg-August-Universität Göttingen

Göttingen, , Germany

Site Status RECRUITING

ALS- und Muskelambulanz, Medizinische Hochschule Hannover

Hanover, , Germany

Site Status RECRUITING

Neurologie und Poliklinik, Universitätsklinikum

Heidelberg, , Germany

Site Status RECRUITING

Ambulanz für Neuromuskuläre und Motoneuron-Erkrankungen, Universitätsklinikum Jena

Jena, , Germany

Site Status RECRUITING

Klinik und Poliklinik für Neurologie

Leipzig, , Germany

Site Status RECRUITING

Klinik für Neuroogie-Präzisionsneurologie, Universitätsklinikum Schleswig-Holstein, Universität zu Lübeck

Lübeck, , Germany

Site Status RECRUITING

Neurologisches Klinik, Ambulanz für Motoneuronerkrankungen und ALS, Diakonissenkrankenhaus

Mannheim, , Germany

Site Status RECRUITING

Universitätklinikum

Mannheim, , Germany

Site Status RECRUITING

Klinik und Poliklinik für Neurologie, Klinikum rechts der Isar der Technischen Universität München

München, , Germany

Site Status RECRUITING

Klinik für Schlafmedizin und Neuromuskuläre Erkrankungen, Westfälische Willhelms-Universität Münster

Münster, , Germany

Site Status RECRUITING

Klinik für Innere Medizin, Neurologie, UKM Marienhospital Steinfurt

Steinfurt, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Thomas Meyer, Prof. Dr.

Role: CONTACT

Senthil Kumar Subramanian, Dr.

Role: CONTACT

+4930810314118

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Christoph Münch, Prof. Dr.

Role: primary

+49 (0)30 450 560132

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EA1/219/15

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

UK SMA Patient Registry
NCT04292574 RECRUITING
Natural History of SMA
NCT05755451 RECRUITING